Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.7508
-0.0218 (-2.82%)
Sep 14, 2026, 12:47 PM EDT - Market open
Filana Therapeutics Market Cap
Filana Therapeutics has a market cap or net worth of $36.27 million as of September 14, 2026. Its market cap has decreased by -64.41% in one year.
Market Cap
36.27M
Enterprise Value
-46.41M
1-Year Change
-64.41%
Ranking
Category
Stock Price
$0.75
ChartMarket Cap Chart
Since July 14, 2000, Filana Therapeutics's market cap has decreased from $565.10M to $36.27M, a decrease of -93.58%. That is a compound annual growth rate of -9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 36.27M | -62.06% |
| Dec 31, 2025 | 95.60M | -15.77% |
| Dec 31, 2024 | 113.50M | -88.04% |
| Dec 29, 2023 | 949.30M | -19.80% |
| Dec 30, 2022 | 1.18B | -32.32% |
| Dec 31, 2021 | 1.75B | 902.69% |
| Dec 31, 2020 | 174.40M | 94.86% |
| Dec 31, 2019 | 89.50M | 513.01% |
| Dec 31, 2018 | 14.60M | -44.70% |
| Dec 29, 2017 | 26.40M | 0.38% |
| Dec 30, 2016 | 26.30M | -67.17% |
| Dec 31, 2015 | 80.10M | -13.78% |
| Dec 31, 2014 | 92.90M | -57.93% |
| Dec 31, 2013 | 220.80M | 80.84% |
| Dec 31, 2012 | 122.10M | -28.01% |
| Dec 30, 2011 | 169.60M | -41.19% |
| Dec 31, 2010 | 288.40M | 27.44% |
| Dec 31, 2009 | 226.30M | -8.97% |
| Dec 31, 2008 | 248.60M | -46.82% |
| Dec 31, 2007 | 467.50M | 18.81% |
| Dec 29, 2006 | 393.50M | 32.67% |
| Dec 30, 2005 | 296.60M | -5.66% |
| Dec 31, 2004 | 314.40M | 28.01% |
| Dec 31, 2003 | 245.60M | 277.85% |
| Dec 31, 2002 | 65.00M | -73.54% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 43.82M |
| aTyr Pharma | 42.16M |
| Veru Inc. | 41.60M |
| Celularity | 40.81M |
| CervoMed | 38.86M |
| Lite Strategy | 37.77M |
| Karyopharm Therapeutics | 36.52M |
| Aligos Therapeutics | 32.60M |